Rzan A. Al-Battat, Basman Medhat Fadheel, Shatha Al-Bayati
email@example.com , firstname.lastname@example.org , Shatha99a@yahoo.com , email@example.com
Rzan A. Al-Battat1, Basman Medhat Fadheel2, Shatha Al-Bayati3
1Dermatologist at College of Medicine Baghdad University, Iraq.
2College of Medicine Baghdad University, Iraq.
3Dermatologist at Al-Yarmouk teaching hospital, Baghdad, Iraq.
Volume - 15,
Issue - 7,
Year - 2022
Background: Suffering from recurrent boils (furunclosis) is a common problem in our locality as it is noticed by many dermatologists especially in association with increasingly hot weather. The most common causative organisms are staphylococci. Objective: The aim of the study was to shed the light upon this problem and compare two systemic therapeutic agents for the prevention of recurrence, doxycycline and rifampicin. Patient and method: One hundred thirty-five (135) Patients with recurrent boils from Al-Yarmouk teaching hospital dermatology outpatient department were included in this study; age ranged from 10 to 64 years old and out of total patients 32 were males and 103 were females. Patients were assessed by full history and clinical examination done by dermatologist. An aspirate from the content of the boil was taken from 30 patients for bacteriological culture. The patients were treated by topical with or without systemic anti-staph antibiotics followed by a preventive protocol of doxycycline100mg twice daily for two months duration in 50 patients and rifampicin 600mg for ten days in the other 85 patients. Both groups used topical sodium fucidate 2% ointment twice daily in nostrils, axilla and perineum for ten days. All were followed up for 2 years to assess the recurrence after treatment. Results: Out of 135 patients treated, 3 (2.22%) patients defaulted from follow up (they were from doxycyclin group) and out of the remainder 132, only 9 (6.8%) patients had recurrence after treatment; 7 (14.89%) patients from the doxycycline group and 3(3.52%) patients from rifampicin group. Forty 40 (85.1%) patients responded well to doxycycline without recurrence for 2 years compared to 83 (97.65%) patients treated with Rifampicin with no recurrence during the 2 years of follow up. The noticed side effects were gastric upset in doxycycline and urine discoloration in rifampicin. Conclusion: Rifampicin regimen in prevention of recurrent boils significantly showed higher effectiveness in addition to more tolerable, easier, shorter course, and fewer side effects than doxycyclin.
Cite this article:
Rzan A. Al-Battat, Basman Medhat Fadheel, Shatha Al-Bayati. Rifampicin versus Doxycycline in Prevention of recurrent Boils (A Comparative Therapeutic Study). Research Journal of Pharmacy and Technology. 2022; 15(7):3041-6. doi: 10.52711/0974-360X.2022.00508
Rzan A. Al-Battat, Basman Medhat Fadheel, Shatha Al-Bayati. Rifampicin versus Doxycycline in Prevention of recurrent Boils (A Comparative Therapeutic Study). Research Journal of Pharmacy and Technology. 2022; 15(7):3041-6. doi: 10.52711/0974-360X.2022.00508 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2022-15-7-30
1. Ibler, K., and Kromann, C. Recurrent furunculosis – challenges and management: a review. Clinical, Cosmetic and Investigational Dermatology. 2014. 59. doi:10.2147/ccid.s35302
2. Sakshi Satyendranarayan Gupta. U.V Radiation Effect on Growth and Survival of Bacteria Staphylococcus aureus. Asian J. Pharm. Ana. 2021; 11(1):27-28.
3. Bhat YJ, Hassan I, Bashir S, Farhana A, Maroof P. Clinico-bacteriological profile of primary pyodermas in Kashmir: a hospital-based study. J R Coll Physicians Edinb. 2016; 46(1): 8-13.
4. Mital N. Manvar. Antibacterial Activity of Leaves and Flowers of Ipomoea aquatica Forsk. (Convolvulacea). Asian J. Pharm. Res. 2018; 8(2): 94-98.
5. Sheetal V. Palande, D. K. Swamy. Study of antimicrobial activity of 2-[(1-Naphthalen-1-yl-ethylimino)-methyl]-phenol and its transition metal complexes on E.coli and Staphylococcus aureus.. Asian J. Research Chem. 2018; 11(1):19-22.
6. Highet AS, Hay RJ and Robert S. Bacterial Infections. In: Textbook of Dermatology. Edited by Champion RH, Burton JL and Ebling FJG. 5th Ed. Blackwell Scientific Publication, Oxford. 1992;2: 953-1030
7. Muthukumaran P, R. Janani. Isolation and Characterization of Lead (Pd) Resistant Staphylococcus aureus from Tannery Effluent Contaminated Site. Research J. Engineering and Tech. 4(4): Oct.-Dec., 2013 page 239-241.
8. Lowy, F. D. Staphylococcus aureus Infections. New England Journal of Medicine1998; 339(8), 520–532. doi:10.1056/nejm199808203390806
9. Bezlon G., Shanmugha Sundhar D., Rinu Edwin R.E. Design and Stabilization of Natural Antibacterial Compound Allicin against Methicillin-Resistant Staphylococcus Aureus for Treatment as a Novel Antibiotic. Research J. Engineering and Tech. 4(4): Oct.-Dec., 2013 page 179-181.
10. Tzermpos, F., Papadimas, C., Theologie-Lygidakis, N., Kanni, T., Tzanetakou, V., Antonopoulou, A., Giamarellos-Bourboulis, E. J. An algorithm for the management of Staphylococcus aureus carriage within patients with recurrent staphylococcal skin infections. Journal of Infection and Chemotherapy. 2013; 19(5): 806– 811. doi:10.1007/s10156-013-0564-2
11. S. D. Mankar, Sahil B. Shaikh, Avesh A. Tamboli. Formulation of Herbal Tablet with the help of Tulsi and Turmeric Extract which Showing Antimicrobial Activity. Research J. Science and Tech. 2020; 12(1): 69-73.
12. El-Gilany, A., and Fathy, H. Risk factors of recurrent furunculosis. Dermatology Online Journal.2009;15 (1). Retrieved from https://escholarship.org/uc/item/9ng6m0bn
13. G. Mahalakshmi, P. Neelusree, M. Kalyani. Phenotypic characterization and Molecular detection of Inducible and Constitutive Clindamycin resistance among Staphylococcus aureus isolates in a Tertiary Care Hospital. Research Journal of Pharmacy and Technology. 2021; 14(7):3799-4.
14. Demos, M., McLeod, M. P., and Nouri, K. Recurrent furunculosis: a review of the literature. British Journal of Dermatology. 2012; 167(4): 725–732. doi:10.1111/j.1365-2133.2012.
15. Co, E.-M., Keen, E. F., and Aldous, W. K. (). Prevalence of Methicillin-Resistant Staphylococcus aureus in a Combat Support Hospital in Iraq. Military Medicine.2011;176(1), 89–93. doi:10.7205/milmed-d-09-00126
16. Saxena, S., Thompson, P., Birger, R., Bottle, A., Spyridis, N., Wong, I. Increasing Skin Infections and Staphylococcus Aureus Complications in Children, England, 1997–2006. Emerging Infectious Diseases.2010; 16(3): 530–533. doi:10.3201/eid1603.090809
17. Arun Duraisamy, Nithya Narayanaswamy, K.P. Balakrishnan. Antioxidant and Anti-Tyrosinase Activity of Some Medicinal Plants. Research J. Pharmacognosy and Phytochemistry 2011; 3(2): 86-90.
18. V. V. Gurale, P. M. D’mello. Evaluation of Antioxidant and Tyrosinase Inhibitory Activity of Punica granatum Flower Extract. Research J. Pharmacognosy and Phytochemistry. 2012; 4(5): 267-270.
19. Abhijit Ray. Protease Enzyme- Potential Industrial Scope. Int. J. Tech. 2(1): Jan.-June. 2012; Page 01-05
20. Hisham A. Abbas. Modulation of antibiotic activity against Pseudomonas aeruginosa by N-acetylcysteine, ambroxol and ascorbic acid. Asian J. Res. Pharm. Sci. 2(4): Oct.-Dec. 2012; Page 123-128
21. Kremer, M., Zuckerman, R., Avraham, Z., and Raz, R. Long-term antimicrobial therapy in the prevention of recurrent soft-tissue infections. Journal of Infection.1991;22(1), 37–40. doi:10.1016/0163-4453(91)90898-3
22. K. Kavipriya, A. Maria Therese, A. Felicia Chitra. Effectiveness of Educational Intervention Programme on Knowledge and Behavioral Competence of Methicillin Resistance Staphylococcus Aureus among Nursing OfficersInt. J. Nur. Edu. and Research. 2019; 7(3):383-385.
23. Aminzadeh, A., Demircay, Z., Ocak, K., and Soyletir, G. Prevention of chronic furunculosis with low‐dose azithromycin. Journal of Dermatological Treatment.2007;18(2): 105– 108. doi:10.1080/09546630601165125
24. SukumaranV., and Senanayake S. Bacterial skin and soft tissue infections. Australian Prescriber.2016, 39(5), 159– 163. doi:10.18773/austprescr.2016.058.
25. Golledge, CL. Management of recurrent furunculosis: treatment guidelines. Current Therapeutics.1999; 40(8): 74-77.
26. Elizabeth A. Campbell, Nataliya Korzheva, Arkady Mustaev, Katsuhiko Murakami, Satish Nair, Alex Goldfarb, Seth A. Darst. Structural Mechanism for Rifampicin Inhibition of Bacterial RNA Polymerase, Cell, 2001; 104(6): 901-912.
27. Russell CD, Lawson McLean A, Saunders C, Laurenson IF (). "Adjunctive rifampicin may improve outcomes in Staphylococcus aureus bacteraemia: a systematic review". Journal of Medical Microbiology. 2014; June, 63 (Pt 6): 841–8.
28. Hardman, Joel G., Lee E. Limbird, and Alfred G. Gilman, eds. "Rifampin." The Pharmacological Basis of Therapeutics. 10th ed. United States of America: The McGraw-Hill Companies, 2001; 1277–1279.
29. Nelson, ML; Levy, SB. The history of the tetracyclines. Annals of the New York Academy of Sciences. 2011; 1241(1): 17
30. Affolter K, Samowitz W, Boynton K, Kelly ED (). Doxycycline-induced gastrointestinal injury. Hum. Pathol. 2017; 66: 212–215
31. Roberts, S A; Lang, S D R. Skin and soft tissue infections, New Zealand Medical Journal.2000; 113(1109): 164-167.
32. Ni Riain, U. Recommended management of common bacterial skin infections. Prescriber. 2011; 22(15-16): 14–24. doi:10.1002/psb.783
33. Falagas, M. E., Bliziotis, I. A., and Fragoulis, K. N. (). Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: A systematic review of the evidence from comparative trials. American Journal of Infection Control.2007; 35(2): 106–114. doi:10.1016/j.ajic.2006.09.005.
34. Creech, C. B., Al-Zubeidi, D. N., and Fritz, S. A. Prevention of Recurrent Staphylococcal Skin Infections. Infectious Disease Clinics of North America. 2015; 29(3): 429–464. doi:10.1016/j.idc.2015.05.007.
35. Xiao, S.-Y., Zhao, L., Hart, J., and Semrad, C. E. Gastric Mucosal Necrosis with Vascular Degeneration Induced by Doxycycline. The American Journal of Surgical Pathology. 2013;37(2), 259–263. doi:10.1097/pas.0b013e31826602d8.
36. McDonnell, G. The Use of Hydrogen Peroxide for Disinfection and Sterilization Applications. In PATAI'S Chemistry of Functional Groups, Z. Rappoport (Ed.). 28 April 2014.
37. Rzan A. Al-Battat, Kawthar M.Taie. Dermatological Diseases among children Attending Al-Yarmouk Teaching Hospital-Outpatient Department of Dermatology. Mustansiriya Medical Journal. 2016, Volume 15, Issue 2, Pages 40-45.
38. Rzan A. Al-Battat. The Pattern Of Skin Diseases Among Kindergarten Children In Baghdad. A Comparative Study Between Two Surveys Five Years Apart. Mustansiriya Medical Journal. 2017, Volume 16, Issue 2, Pages 50-53.